Keiji Dohi

661 total citations
12 papers, 235 citations indexed

About

Keiji Dohi is a scholar working on Oncology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Keiji Dohi has authored 12 papers receiving a total of 235 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Organic Chemistry and 3 papers in Molecular Biology. Recurrent topics in Keiji Dohi's work include HER2/EGFR in Cancer Research (3 papers), Quinazolinone synthesis and applications (2 papers) and Peptidase Inhibition and Analysis (2 papers). Keiji Dohi is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Quinazolinone synthesis and applications (2 papers) and Peptidase Inhibition and Analysis (2 papers). Keiji Dohi collaborates with scholars based in Japan and United States. Keiji Dohi's co-authors include Teruaki HIDAKA, Yoshio Terauchi, Michinari Hirata, Kazunari Hattori, Yuji Sato, Hideaki Hanaki, Akira Sato, Masahiro Nakamura, Akira Kikuchi and Ikuko Tsujimoto and has published in prestigious journals such as Scientific Reports, Clinical Chemistry and Vaccine.

In The Last Decade

Keiji Dohi

12 papers receiving 224 citations

Peers

Countries citing papers authored by Keiji Dohi

Since Specialization

Citations

This map shows the geographic impact of Keiji Dohi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiji Dohi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiji Dohi more than expected).

Fields of papers citing papers by Keiji Dohi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiji Dohi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiji Dohi. The network helps show where Keiji Dohi may publish in the future.

Co-authorship network of co-authors of Keiji Dohi

This figure shows the co-authorship network connecting the top 25 collaborators of Keiji Dohi. A scholar is included among the top collaborators of Keiji Dohi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiji Dohi. Keiji Dohi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys 2022 ·Vaccine ·(unknown), Noriyo Nagata, Tomoyuki Homma, Hiroki Maeda, Keiji Dohi, (unknown), (unknown), Naoko Iwata‐Yoshikawa, (unknown), Yusuke Sakai, Masayuki Shirakura, Noriko Kishida, (unknown), Yasushi Suzuki, Shinji Watanabe, Hideki Asanuma, Takuhiro Sonoyama, Tadaki Suzuki, Shinya Omoto, Hideki Hasegawa	11
2	Development of a new knock-in mouse model and evaluation of pharmacological activities of lusutrombopag, a novel, nonpeptidyl small-molecule agonist of the human thrombopoietin receptor c-Mpl 2017 ·Experimental Hematology ·Hiroshi Yoshida, Hajime Yamada, (unknown), Keiji Dohi, (unknown), Koji Sugiyama, Koji Takahashi, Yoshinari Gahara, Motoji Kitaura, Minoru Hasegawa, I Oshima, Kenji Kuwabara	7
3	Wnt5a promotes cancer cell invasion and proliferation by receptor-mediated endocytosis-dependent and -independent mechanisms, respectively 2015 ·Scientific Reports ·Kensaku Shojima, Akira Sato, Hideaki Hanaki, Ikuko Tsujimoto, Masahiro Nakamura, Kazunari Hattori, Yuji Sato, Keiji Dohi, Michinari Hirata, Hideki Yamamoto, Akira Kikuchi	58
4	Preclinical antitumor activity of S‐222611, an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2 2014 ·Cancer Science ·Hidekazu Tanaka, Michinari Hirata, (unknown), Toru Wada, (unknown), Keiji Dohi, Makiko Inoue, (unknown), Kanji Hojo, Tomomi Yamada, Tatsuya Sugimoto, (unknown), (unknown), Norihito Sato, Kenji Matsuo, Shuji Yonezawa, Eugene P. Frenkel, Michitaka Shichijo	21
5	Synthesis and evaluation of novel pyrimidine-based dual EGFR/Her-2 inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·Naoyuki Suzuki, Takeshi Shiota, Fumihiko Watanabe, (unknown), (unknown), Takafumi Ohara, Kenji Matsuo, (unknown), (unknown), Keiji Dohi, Makiko Inoue, (unknown), (unknown), (unknown)	23
6	Discovery of novel 5-alkynyl-4-anilinopyrimidines as potent, orally active dual inhibitors of EGFR and Her-2 tyrosine kinases 2011 ·Bioorganic & Medicinal Chemistry Letters ·Naoyuki Suzuki, Takeshi Shiota, Fumihiko Watanabe, (unknown), (unknown), Takafumi Ohara, Kenji Matsuo, (unknown), (unknown), Keiji Dohi, Makiko Inoue, (unknown), (unknown), (unknown)	15
7	High-throughput miniaturized immunoassay for human interleukin-13 secreted from NK3.3 cells using homogenous time-resolved fluorescence 2002 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), (unknown), Toshihiro Nakajima, (unknown), Keiji Dohi, (unknown), P. Seguin, Gérard Mathis, Ryuji Suzuki, Goro Kominami, Hiroshi Takemoto	8
8	Immunoradiometric assay for the N-terminal fragment of proatrial natriuretic peptide in human plasma. 1998 ·PubMed ·Yoshito Numata, Keiji Dohi, Ayako Furukawa, (unknown), (unknown), (unknown), Y. Taniguchi, Kazuyuki Sasakura, Tetsuo Tsuji, Ken Inouye, Michihiro Yoshimura, Hiroshi Itoh, Masashi Mukoyama, Hirofumi Yasue, Kazuwa Nakao	23
9	Immunoradiometric assay for the N-terminal fragment of proatrial natriuretic peptidein human plasma 1998 ·Clinical Chemistry ·Yoshito Numata, Keiji Dohi, Ayako Furukawa, (unknown), (unknown), (unknown), Y. Taniguchi, Kazuyuki Sasakura, Tetsuo Tsuji, Ken Inouye, Michihiro Yoshimura, Hiroshi Itoh, Masashi Mukoyama, Hirofumi Yasue, Kazuwa Nakao	21
10	Improved Purification of Arylsulfate Sulfotransferase from Human Intestinal Bacterium by Using Polyclonal Antibody 1994 ·The Journal of Biochemistry ·(unknown), Keiji Dohi, (unknown), Kyoichi Kobashi	3
11	Enzymatic Sulfation of Isoamyl Gallate and (-)-Epigallocatechin Gallate by Bacterial Arylsulfotransferase. 1992 ·Chemical and Pharmaceutical Bulletin ·(unknown), Teruaki Akao, Lisa Imamura, Keiji Dohi, Takashi Yoshida, Takuo Okuda, Kyoichi Kobashi	10
12	On the Relation between the Run-Out Errors and the Motion of the Center of Sun Gear In a Stoeckicht Planetary Gear 1979 ·Bulletin of JSME ·Teruaki HIDAKA, Yoshio Terauchi, Keiji Dohi	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact